{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T01:04:31Z","timestamp":1790989471761,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["L'Enc\u00e9phale"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.encep.2009.03.010","type":"journal-article","created":{"date-parts":[[2009,8,30]],"date-time":"2009-08-30T08:09:23Z","timestamp":1251619763000},"page":"D119-D123","source":"Crossref","is-referenced-by-count":9,"special_numbering":"S2","title":["Antid\u00e9presseurs s\u00e9rotoninergiques et antalgiques opiac\u00e9s\u00a0: une association parfois \u00ab\u00a0douloureuse\u00a0\u00bb\u00a0! \u00c0 propos d\u2019un cas clinique"],"prefix":"10.1016","volume":"36","author":[{"given":"M.","family":"Reich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Lefebvre-Kuntz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.encep.2009.03.010_bib1","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2710.2007.00813.x","article-title":"Serotonin syndrome caused by interaction between citalopram and fentanyl","volume":"32","author":"Ailawadhi","year":"2007","journal-title":"J Clin Pharm Ther"},{"issue":"3","key":"10.1016\/j.encep.2009.03.010_bib2","first-page":"97","article-title":"Le syndrome s\u00e9rotoninergique\u00a0: un risque latent en soins palliatifs","volume":"12","author":"Anderson","year":"2005","journal-title":"J Eur Soins Palliat (JESP)"},{"issue":"11","key":"10.1016\/j.encep.2009.03.010_bib3","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1056\/NEJMra041867","article-title":"The serotonin syndrome","volume":"352","author":"Boyer","year":"2005","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.encep.2009.03.010_bib4","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0733-8627(05)70127-9","article-title":"The neuroleptic malignant and serotonin syndromes","volume":"18","author":"Carbone","year":"2000","journal-title":"Emerg Med Clin North Am"},{"key":"10.1016\/j.encep.2009.03.010_bib5","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1124\/jpet.105.095109","article-title":"High-efficacy 5-hydroxytryptamine 1A\u00a0receptor activation counteracts opioid hyperallodynia and affective conditioning","volume":"316","author":"Colpaert","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.encep.2009.03.010_bib6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00002826-199619020-00004","article-title":"Ectasy intoxication: an overlap between serotonin syndrome and neuroleptic malignant syndrome","volume":"19","author":"Demirkiran","year":"1996","journal-title":"Clin Neuropharmacol"},{"issue":"3","key":"10.1016\/j.encep.2009.03.010_bib7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00004850-199705000-00010","article-title":"Serotonin syndrome attributed to tramadol addition to paroxetine therapy","volume":"12","author":"Egberts","year":"1997","journal-title":"Int Clin Psychopharmacol"},{"issue":"1","key":"10.1016\/j.encep.2009.03.010_bib8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1526-4637.2003.03005.x","article-title":"Serotonin syndrome and other serotonergic disorders","volume":"4","author":"Ener","year":"2003","journal-title":"Pain Med"},{"issue":"2","key":"10.1016\/j.encep.2009.03.010_bib9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/YIC.0b013e3280128d16","article-title":"Cost-effectiveness of escitalopram vs citalopram in major depressive disorder","volume":"22","author":"Fantino","year":"2007","journal-title":"Int Clin Psychopharmacol"},{"issue":"6","key":"10.1016\/j.encep.2009.03.010_bib10","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00004714-199512000-00009","article-title":"Serotonin syndrome in the elderly after antidepressive monotherapy","volume":"15","author":"Fischer","year":"1995","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"10.1016\/j.encep.2009.03.010_bib11","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/00004714-199704000-00017","article-title":"Serotonin syndrome treated with chlorpromazine","volume":"17","author":"Gillman","year":"1997","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"10.1016\/j.encep.2009.03.010_bib12","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jamda.2005.04.012","article-title":"Interaction of serotoninergic antidepressants and opioid analgesics: is serotonin syndrome going undetected?","volume":"6","author":"Gnanadesigan","year":"2005","journal-title":"J Am Med Dir Assoc"},{"issue":"4","key":"10.1016\/j.encep.2009.03.010_bib13","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0736-4679(98)00057-2","article-title":"Treatment of the serotonin syndrome with cyproheptadine","volume":"16","author":"Graudins","year":"1998","journal-title":"J Emerg Med"},{"issue":"1","key":"10.1016\/j.encep.2009.03.010_bib14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00004714-200002000-00020","article-title":"Serotonin syndrome during treatment with paroxetine and risperidone","volume":"20","author":"Hamilton","year":"2000","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"10.1016\/j.encep.2009.03.010_bib15","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1345\/aph.1A302","article-title":"Severe serotonin syndrome induced by mirtazapine monotherapy","volume":"36","author":"Hernandez","year":"2002","journal-title":"Ann Pharmacother"},{"issue":"3","key":"10.1016\/j.encep.2009.03.010_bib16","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1345\/aph.1D344","article-title":"Serotonin syndrome resulting from coadministration of tramadol, venlafaxine, and mirtazapine","volume":"38","author":"Houlihan","year":"2004","journal-title":"Ann Pharmacother"},{"issue":"4","key":"10.1016\/j.encep.2009.03.010_bib17","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1017\/S1092852900021027","article-title":"Serotonin syndrome associated with the use of escitalopram","volume":"12","author":"Huska","year":"2007","journal-title":"CNS Spectr"},{"issue":"3","key":"10.1016\/j.encep.2009.03.010_bib18","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1081\/CLT-120037428","article-title":"Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose","volume":"42","author":"Isbister","year":"2004","journal-title":"J Toxicol Clin Toxicol"},{"issue":"34","key":"10.1016\/j.encep.2009.03.010_bib19","first-page":"1695","article-title":"Le syndrome s\u00e9rotoninergique. Quel traitement et quand\u00a0?","volume":"30","author":"Jaunay","year":"2001","journal-title":"Presse Med"},{"issue":"3","key":"10.1016\/j.encep.2009.03.010_bib20","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1345\/aph.1C228","article-title":"Combinaison risperidone and SSRI-induced serotonin syndrome","volume":"37","author":"Karki","year":"2003","journal-title":"Ann Pharmacother"},{"issue":"1","key":"10.1016\/j.encep.2009.03.010_bib21","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1345\/aph.1E671","article-title":"Serotonin syndrome induced by fluvoxamine and oxycodone","volume":"40","author":"Karunatilake","year":"2006","journal-title":"Ann Pharmacother"},{"issue":"2","key":"10.1016\/j.encep.2009.03.010_bib22","first-page":"122","article-title":"Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis","volume":"31","author":"Kennedy","year":"2006","journal-title":"J Psychiatry Neurosci"},{"issue":"5","key":"10.1016\/j.encep.2009.03.010_bib23","first-page":"422","article-title":"Syndrome s\u00e9rotoninergique","volume":"23","author":"Lheureux","year":"2002","journal-title":"Rev Med Brux"},{"issue":"11","key":"10.1016\/j.encep.2009.03.010_bib24","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0025-7753(07)72615-5","article-title":"Possible serotoninergic syndrome associated with coadministration of paroxetine and tramadol","volume":"128","author":"Llinares-Tello","year":"2007","journal-title":"Med Clin (Barc)"},{"issue":"448","key":"10.1016\/j.encep.2009.03.010_bib25","first-page":"871","article-title":"Antidepressants and the serotonin syndrome in general practice","volume":"49","author":"Mackay","year":"1999","journal-title":"Br J Gen Pract"},{"issue":"6","key":"10.1016\/j.encep.2009.03.010_bib26","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1176\/appi.ajp.161.6.1129","article-title":"Serotonin syndrome with tramadol and citalopram","volume":"16","author":"Mahlberg","year":"2004","journal-title":"Am J Psychiatry"},{"issue":"2","key":"10.1016\/j.encep.2009.03.010_bib27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/106002809703100208","article-title":"Possible serotonin syndrome associated with tramadol and sertraline coadministration","volume":"31","author":"Mason","year":"1997","journal-title":"Ann Pharmacother"},{"issue":"7-8","key":"10.1016\/j.encep.2009.03.010_bib28","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1345\/aph.10203","article-title":"Serotonin syndrome: early management with cyproheptadine","volume":"35","author":"Mcdaniel","year":"2001","journal-title":"Ann Pharmacother"},{"issue":"3","key":"10.1016\/j.encep.2009.03.010_bib29","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0022-3565(25)22987-1","article-title":"5-hydroxytryptamine (HT)1A receptors and the tail-flick response. II.\u00a0High efficacy 5-HT1A agonists attenuate morphine-induced antinociception in mice in a competitive-like manner","volume":"256","author":"Millan","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"issue":"16","key":"10.1016\/j.encep.2009.03.010_bib30","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.2165\/00003495-200565160-00013","article-title":"Escitalopram: a review of its use in the management of major depressive disorder","volume":"65","author":"Murdoch","year":"2005","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.encep.2009.03.010_bib31","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.encep.2009.03.010_bib32","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1345\/aph.1C021","article-title":"Serotonin syndrome induced by low-dose venlafaxine","volume":"37","author":"Pan","year":"2003","journal-title":"Ann Pharmacother"},{"issue":"3","key":"10.1016\/j.encep.2009.03.010_bib33","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1054\/mehy.2000.1047","article-title":"An exploratory approach to the serotonin syndrome: an update of clinical phenomenology and revised diagnosis criteria","volume":"55","author":"Radomski","year":"2000","journal-title":"Med Hypotheses"},{"issue":"4","key":"10.1016\/j.encep.2009.03.010_bib34","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2165\/00003088-200746040-00002","article-title":"The clinical pharmacokinetics of escitalopram","volume":"46","author":"Rao","year":"2007","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"10.1016\/j.encep.2009.03.010_bib35","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1177\/00912700122009926","article-title":"Visual hallucination and tremor induced by sertraline and oxycodone in a bone marrow transplant patient","volume":"41","author":"Rosebraugh","year":"2000","journal-title":"J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.encep.2009.03.010_bib36","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s00210-001-0508-8","article-title":"Supersensitivity of 5-HT1A autoreceptors and \u03b12-adrenoceptors regulating monoamine synthesis in the brain of morphine-dependent rats","volume":"365","author":"Sastre-Coll","year":"2002","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"10.1016\/j.encep.2009.03.010_bib37","doi-asserted-by":"crossref","first-page":"29","DOI":"10.5387\/fms.52.29","article-title":"Serotonin syndrome caused by minimum doses of SSRIS in a patient with spinal cord injury","volume":"52","author":"Satoh","year":"2006","journal-title":"Fukushima J Med Sci"},{"issue":"6","key":"10.1016\/j.encep.2009.03.010_bib38","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1176\/ajp.148.6.705","article-title":"The serotonin syndrome","volume":"148","author":"Sternbach","year":"1991","journal-title":"Am J Psychiatry"}],"container-title":["L'Enc\u00e9phale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700609001341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700609001341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T22:37:23Z","timestamp":1739313443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0013700609001341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":38,"alternative-id":["S0013700609001341"],"URL":"https:\/\/doi.org\/10.1016\/j.encep.2009.03.010","relation":{},"ISSN":["0013-7006"],"issn-type":[{"value":"0013-7006","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}